CYP27A1 and breast cancer: Nevertheless, Baek et al. [80] showed that inhibition of CYP27A1 by the small molecule GW273297X significantly reduced breast cancer colonisation of the lungs in two animal models, indicating that targeting CYP27A1 may provide a therapeutic intervention.